PAR paradigm biopharmaceuticals limited..

Great reading as always Mozz.Have you read this paper from last...

  1. 788 Posts.
    lightbulb Created with Sketch. 147
    Great reading as always Mozz.

    Have you read this paper from last month? Pentosan Polysulphate (PPS), a Semi-Synthetic Heparinoid DMOAD With Roles in Intervertebral Disc Repair Biology emulating The Stem Cell Instructive and Tissue Reparative Properties of Heparan Sulphate

    https://www.liebertpub.com/doi/10.1089/scd.2022.0007?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

    I'm half way through, pretty damn hard to read so far but seemingly more evidence for the pile.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
44.5¢
Change
0.015(3.49%)
Mkt cap ! $176.8M
Open High Low Value Volume
45.0¢ 45.0¢ 43.0¢ $364.9K 828.8K

Buyers (Bids)

No. Vol. Price($)
2 55155 43.5¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 24999 2
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.